Additional Indications Below for Module 4 and 5
1 clinical trials · Condition
◉ Watch Additional Indications Below for Module 4 and 5
| Record | Firm | Date |
|---|---|---|
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
Track Additional Indications Below for Module 4 and 5 automatically
Every clearance here is in the API, with alerts when new ones post.